{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:58:38Z","timestamp":1792292318841,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jocn.2025.111669","type":"journal-article","created":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T17:22:18Z","timestamp":1760289738000},"page":"111669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Assessing sleep disorders in neuromyelitis optica spectrum disorder: A comparison of qualitative and quantitative approaches"],"prefix":"10.1016","volume":"142","author":[{"given":"Sabiha","family":"T\u00fcre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enise Nur","family":"\u00d6zlem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihat","family":"Uzunk\u00f6pr\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"\u00d6zakba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jocn.2025.111669_b0005","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jocn.2025.111669_b0010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jocn.2025.111669_b0015","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jocn.2025.111669_b0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00424-011-1044-0","article-title":"Sleep and immune function","volume":"463","author":"Besedovsky","year":"2012","journal-title":"Pflugers Arch Eur J Physiol"},{"issue":"3","key":"10.1016\/j.jocn.2025.111669_b0025","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00010.2018","article-title":"The sleep-immune crosstalk in health and disease","volume":"99","author":"Besedovsky","year":"2019","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.jocn.2025.111669_b0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00415-009-0139-4","article-title":"Narcolepsy as an initial manifestation of neuromyelitis optica with antiaquaporin-4 antibody","volume":"256","author":"Baba","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2025.111669_b0035","article-title":"101869","author":"Beigneux","year":"2019","journal-title":"Available from:"},{"key":"10.1016\/j.jocn.2025.111669_b0040","doi-asserted-by":"crossref","unstructured":"Hyun JW, Kim SH, Jeong IH, Joung AR, Kim JH, Cho HJ, et al. Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder. Sleep Med [Internet]. 2016;17:121\u20133. Available from: http:\/\/dx.doi.org\/10.1016\/j.sleep.2015.08.023.","DOI":"10.1016\/j.sleep.2015.08.023"},{"key":"10.1016\/j.jocn.2025.111669_b0045","doi-asserted-by":"crossref","unstructured":"Shaygannejad V, Sadeghi Bahmani D, Soleimani P, Mirmosayyeb O, Barzegar M, Amra B, et al. Comparison of prevalence rates of restless legs syndrome, self-assessed risks of obstructive sleep apnea, and daytime sleepiness among patients with multiple sclerosis (MS), clinically isolated syndrome (CIS) and Neuromyelitis Optica Spectrum Disorder (NM. Sleep Med [Internet]. 2020;70:97\u2013105. Available from: https:\/\/doi.org\/10.1016\/j.sleep.2019.11.1266.","DOI":"10.1016\/j.sleep.2019.11.1266"},{"issue":"3","key":"10.1016\/j.jocn.2025.111669_b0050","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1212\/NXI.0000000000000094","article-title":"Sleep abnormality in neuromyelitis optica spectrum disorder","volume":"2","author":"Song","year":"2015","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"key":"10.1016\/j.jocn.2025.111669_b0055","doi-asserted-by":"crossref","unstructured":"Sousa NAC, de Almeida CMO, Takano SAF, Souza SPL, Rabelo RMP. Sleep in multiple sclerosis and neuromyelitis optica spectrum disorder\u2014the SEMN study. Sleep Breath [Internet]. 2023;27(6):2453\u20138. Available from: https:\/\/doi.org\/10.1007\/s11325-023-02824-1.","DOI":"10.1007\/s11325-023-02824-1"},{"key":"10.1016\/j.jocn.2025.111669_b0060","first-page":"1","volume":"5","author":"Ishido","year":"2023","journal-title":"Characteristics of hypersomnia due to inflammatory demyelinating diseases of the central nervous system"},{"key":"10.1016\/j.jocn.2025.111669_b0065","doi-asserted-by":"crossref","unstructured":"Luo W, Fang L, Wang Z, Liu Z, Liao J, Meng Z, et al. Hypothalamic lesions in neuromyelitis optica spectrum disorders\u00a0: exploring a scoring system based on magnetic resonance imaging. Jpn J Radiol [Internet]. 2021;39(7):659\u201368. Available from: https:\/\/doi.org\/10.1007\/s11604-021-01104-w.","DOI":"10.1007\/s11604-021-01104-w"},{"key":"10.1016\/j.jocn.2025.111669_b0070","doi-asserted-by":"crossref","unstructured":"Etemadifar M, Nouri H, Khorvash R, Salari M, Ghafari K, Aghababaee A. Frequency of diencephalic syndrome in NMOSD. Acta Neurol Belg [Internet]. 2022;122(4):961\u20137. Available from: https:\/\/doi.org\/10.1007\/s13760-021-01792-1.","DOI":"10.1007\/s13760-021-01792-1"},{"issue":"3","key":"10.1016\/j.jocn.2025.111669_b0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7224\/1537-2073.2021-019","article-title":"Sleep Quality in Neuromyelitis Optica Spectrum Disorder: a Systematic Review","volume":"24","author":"Eshtiaghi","year":"2022","journal-title":"Int J MS Care"},{"issue":"2","key":"10.1016\/j.jocn.2025.111669_b0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"issue":"6","key":"10.1016\/j.jocn.2025.111669_b0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.jocn.2025.111669_b0090","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/ALN.0b013e31816d83e4","article-title":"A Tool to Screen patients for Obstructive sleep Apnea","volume":"108","author":"Chung","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jocn.2025.111669_b0095","doi-asserted-by":"crossref","unstructured":"Allen RP, Picchietti DL, Garcia-borreguero D, Ondo WG, Walters AS, Winkelman JW, et al. Restless legs syndrome \/ Willis \u2013 Ekbom disease diagnostic criteria\u00a0: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria \u2013 history , rationale , description, and significance. Sleep Med [Internet]. 2014;15(8):860\u201373. Available from: http:\/\/dx.doi.org\/10.1016\/j.sleep.2014.03.025.","DOI":"10.1016\/j.sleep.2014.03.025"},{"issue":"3","key":"10.1016\/j.jocn.2025.111669_b0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1389-9457(00)00080-0","article-title":"Validation of the Johns Hopkins restless legs severity scale","volume":"2","author":"Allen","year":"2001","journal-title":"Sleep Med"},{"issue":"2","key":"10.1016\/j.jocn.2025.111669_b0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome","volume":"4","author":"Horiguchi","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.jocn.2025.111669_b0110","first-page":"1","author":"Beck","year":"1996","journal-title":"Comparison of Beck Depression Inventories - IA and - II in psychiatric outpatients"},{"key":"10.1016\/j.jocn.2025.111669_b0115","first-page":"357","article-title":"Bidirectional communication betweenthe Brain and the Immune System: Implications for Physiological sleep and Disorders with Disrupted sleep","volume":"2007","author":"Lorton","year":"2007","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jocn.2025.111669_b0120","doi-asserted-by":"crossref","unstructured":"Beigneux Y, Arnulf I, Guillaume-Jugnot P, Leu-Semenescu S, Maillart E, Lubetzki C, et al. Secondary hypersomnia as an initial manifestation of neuromyelitis optica spectrum disorders. Mult Scler Relat Disord [Internet]. 2020;38:101869. Available from: https:\/\/doi.org\/10.1016\/j.msard.2019.101869.","DOI":"10.1016\/j.msard.2019.101869"},{"key":"10.1016\/j.jocn.2025.111669_b0125","doi-asserted-by":"crossref","unstructured":"Shaygannejad V, Sadeghi D, Soleimani P. Comparison of prevalence rates of restless legs syndrome , self-assessed risks of obstructive sleep apnea , and daytime sleepiness among patients with multiple sclerosis (MS), clinically isolated syndrome (CIS) and Neuromyelitis Optica Spectrum Disord. Sleep Med [Internet]. 2020;70:97\u2013105. Available from: https:\/\/doi.org\/10.1016\/j.sleep.2019.11.1266.","DOI":"10.1016\/j.sleep.2019.11.1266"},{"key":"10.1016\/j.jocn.2025.111669_b0130","doi-asserted-by":"crossref","unstructured":"Liu J, Zhang X, Zhong Y, Liu X. The prevalence of depression , anxiety , and sleep disturbances in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis. Mult Scler Relat Disord [Internet]. 2023;79(September):105007. Available from: https:\/\/doi.org\/10.1016\/j.msard.2023.105007.","DOI":"10.1016\/j.msard.2023.105007"},{"issue":"5","key":"10.1016\/j.jocn.2025.111669_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0177230","article-title":"Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life","volume":"12","author":"Seok","year":"2017","journal-title":"PLoS One"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825006423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586825006423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:37:27Z","timestamp":1770309447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586825006423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"alternative-id":["S0967586825006423"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111669","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing sleep disorders in neuromyelitis optica spectrum disorder: A comparison of qualitative and quantitative approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2025.111669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111669"}}